Study compares immune responses from three major COVID-19 vaccine types

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

Moderna (MRNA): Reassessing Valuation After FDA Signals Tougher Vaccine Approval Standards

Moderna (MRNA) slipped about 6% after an FDA official said future vaccine approvals will face tougher scrutiny, a shift tied ...
Just The NewsOpinion

Pfizer buries data showing mRNA flu vaccine bombed in trial with elderly, not much better under 65

More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...
Irish Medical TimesOpinion

The benefits of mRNA COVID-19 vaccines appear to go way beyond protection against the COVID-19 virus

C OVID-19 mRNA vaccines that saved millions of lives globally during the pandemic from 2021 onwards, have now been reported ...

Adjustable DNA 'shield' can control timing and rate at which mRNA produces proteins in vivo

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...